Andy Chevigné and his team, RTI-5152-12 is postulated to raise the levels of opioid peptides that bind to classical opioid receptors within the brain, causing heightened painkilling activity. The LIH-RTI exploration teams recognized a collaboration agreement and submitted a joint patent application in December 2020.Please talk to your healthcare p